Specialty and fermentation APIs — Business MegaBrands 2026–27

This category covers Indian manufacturers of complex active pharmaceutical ingredients, including those made by fermentation, high-potency oncology compounds, contrast media and immunosuppressants. Production calls for specialised containment, biological processes and tight quality control. These firms add capability in molecules that few countries make at commercial scale, and reduce dependence on imports for difficult-to-produce inputs.

Slot BMB-172 · APIs · 6 brands in contention · Business MegaBrand: to be announced in 2027

Brands in contention

Listed alphabetically. The order does not reflect evaluation.

How this category is evaluated

Every brand in this category is assessed on WCRC's 50-parameter brand evaluation model, across five pillars: Brand Positioning & Recall, Trust & Sentiment, Product, Innovation & Delivery, Sustainability, Governance & ESG, and Digital & Financial Soundness. Scores are compared within the category, and the brand with the strongest result is named the Business MegaBrand. Read the methodology

Frequently asked

Which companies make specialty and fermentation-based APIs in India?

In the Business MegaBrands 2026–27 cohort, the brands in contention for specialty and fermentation APIs are Alivus Life Sciences, Blue Jet Healthcare, Cohance Lifesciences, Concord Biotech, Shilpa Medicare and Vasudha Pharma. This is a list, not a ranking. WCRC will name one Business MegaBrand after its independent 50-parameter evaluation of every brand in contention.

Other categories in APIs

• APIs and intermediates — large
• Generic APIs — mid-size

All of Pharma, Life Sciences & Medtech · The 2026–27 cohort

Cite this page: WCRC, Business MegaBrands 2026–27, Specialty and fermentation APIs (Slot BMB-172), https://www.mostvaluablebrands.com/business-megabrands/2026-27/pharma-life-sciences-and-medtech/specialty-and-fermentation-apis/, accessed [date].

WCRC network: WCRC International · WCRC Leaders